Industry

DUBLIN–(BUSINESS WIRE)–The “Global Bio Decontamination Market by Product (Equipment, Services, Consumables), Agent (Hydrogen Peroxide, Nitrogen, Peracetic Acid), Type (Room Decontamination, Chamber Decontamination), End User (Hospitals & Healthcare Facilities) – Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The global bio decontamination market is projected to reach USD 227 million by 2027 from USD … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Royalty Rates for Medical Devices 2022” report has been added to ResearchAndMarkets.com’s offering. Royalty Rates for Medical Devices & Diagnostics is all about royalty rates from the medical device industry. It is based on decades of research. The rates in this book can be used for negotiating licenses, valuing medical technology and establishing … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “US Biosimilar Market: Insights & Forecast with Potential Impact of COVID- 19 (2022-2026)” report has been added to ResearchAndMarkets.com’s offering. The US biosimilar market is forecasted to reach US$36.16 billion in 2026, experiencing growth at a CAGR of 40.16% during the period spanning from 2022 to 2026. Growth in the US biosimilar market … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Cancer Vaccine Market & Clinical Trials Outlook 2028” report has been added to ResearchAndMarkets.com’s offering. The global cancer vaccine market is expected to surpass US$ 15 Billion by 2028. The significant increase in the growth of the market is mainly attributed to encouraging sales of HPV cancer vaccines and rising awareness among … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–InterVenn Biosciences, a clinical technology company leveraging glycoproteomics to transform the future of healthcare, today announced that it has expanded its global presence with the opening of multiple new locations in Asia-Pacific and North America. The company’s new facilities include Mandaluyong, Philippines; Kuala Lumpur, Malaysia; Melbourne, Australia; and San Diego, California, adding a … [Read more…]

CARLSBAD, Calif.–(BUSINESS WIRE)–Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2022 financial results on August 4, 2022, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. … [Read more…]

ROCKVILLE, Md.–(BUSINESS WIRE)–AIM-HI Accelerator Fund, a non-for-profit that focuses on supporting early-stage biotechnology companies to progress innovative discoveries into the clinic, announced today that Mr. Lance Kawaguchi, CEO of Cure Brain Cancer Foundation, has been appointed as a strategic advisor. AIM-HI’s prestigious strategic advisors are comprised of the world’s leaders in biotechnology commercialization and oncology … [Read more…]

COLLEGE STATION, Texas–(BUSINESS WIRE)–Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, hosted an inaugural event this week, Global Cell & Gene Day, with CHA Medical & Bio Group, providing a specialized venue for learning, innovation and networking for the … [Read more…]

Medidata Sensor Cloud Network to include Aural Analytics’ industry leading, integrated speech analytics platform—Speech Vitals. PHOENIX–(BUSINESS WIRE)–#AuralAnalytics—Aural Analytics, Inc., a leader in clinical-grade speech analytics, announced they have entered into a partnership with Medidata, a Dassault Systèmes company, enabling speech analytics as part of the Medidata Sensor Cloud Network. Aural Analytics’ best-in-class speech platform Speech … [Read more…]

– Data Show that HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Reduced Relapse Rate Versus Placebo in CIDP Patients When Used as a Maintenance Therapy – Company Continues to Analyze Data with Goal of Submitting Regulatory Applications in the US and EU in FY2022 OSAKA, Japan & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Takeda (TSE:4502/NYSE:TAK) today … [Read more…]